Lucia Conti
Overview
Explore the profile of Lucia Conti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
503
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fertitta V, Varano B, Del Corno M, Fortini P, Aureli A, Conti L
Biomolecules
. 2025 Jan;
14(12.
PMID: 39766278
Lipopolysaccharide (LPS) is a potent endotoxin released at high concentrations in acute infections, causing massive host inflammatory response. Accumulating evidence indicates that dysbiosis-associated chronic low levels of circulating LPS can...
2.
Tait S, Calura E, Baldassarre A, Masotti A, Varano B, Gessani S, et al.
Int J Mol Sci
. 2024 Mar;
25(6).
PMID: 38542331
Colorectal cancer (CRC) is a major life-threatening disease, being the third most common cancer and a leading cause of death worldwide. Enhanced adiposity, particularly visceral fat, is a major risk...
3.
Hamoudi R, Conti L, Olive D, MacRobert A
Front Immunol
. 2023 Dec;
14:1325619.
PMID: 38106425
No abstract available.
4.
Cignarella A, Vegeto E, Bolego C, Trabace L, Conti L, Ortona E
Pharmacol Res
. 2023 Oct;
197:106956.
PMID: 37820857
Several immunopharmacological agents are effective in the treatment of cancer and immune-mediated conditions, with a favorable impact on life expectancy and clinical outcomes for a large number of patients. Nevertheless,...
5.
Aureli A, Del Corno M, Marziani B, Gessani S, Conti L
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612048
Colorectal cancer (CRC) is a leading cause of death worldwide. Despite advances in surgical and therapeutic management, tumor metastases and resistance to therapy still represent major hurdles. CRC risk is...
6.
Bracci L, Fabbri A, Del Corno M, Conti L
Cancers (Basel)
. 2021 Sep;
13(18).
PMID: 34572726
Colorectal cancer (CRC) is a major cancer type and a leading cause of death worldwide. Despite advances in therapeutic management, the current medical treatments are not sufficient to control metastatic...
7.
Del Corno M, Vari R, Scazzocchio B, Varano B, Masella R, Conti L
Cells
. 2021 Aug;
10(7).
PMID: 34359908
Colorectal cancer (CRC) is among the major threatening diseases worldwide, being the third most common cancer, and a leading cause of death, with a global incidence expected to increase in...
8.
Del Corno M, Gessani S, Conti L
Cancers (Basel)
. 2020 Jan;
12(1).
PMID: 31936360
β-glucans represent a heterogeneous group of naturally occurring and biologically active polysaccharides found in many kinds of edible mushrooms, baker's yeast, cereals and seaweeds, whose health-promoting effects have been known...
9.
Conti L, Del Corno M, Gessani S
Crit Rev Oncol Hematol
. 2019 Dec;
145:102834.
PMID: 31790930
Colorectal cancer (CRC) is a leading cause of cancer-related mortality in the world. Patterns and trends in CRC incidence and mortality correlate with increasing adoption of Western lifestyles and with...
10.
Del Corno M, Baldassarre A, Calura E, Conti L, Martini P, Romualdi C, et al.
Front Immunol
. 2019 Mar;
10:265.
PMID: 30838002
Obesity, a low-grade inflammatory condition, represents a major risk factor for the development of several pathologies including colorectal cancer (CRC). Although the adipose tissue inflammatory state is now recognized as...